Healthcare Business

Why Melinta Therapeutics Shares Are Getting Crushed

Melinta Therapeutics Inc. (NASDAQ: MLNT) saw its shares plunge on Thursday after the firm announced that it had priced its secondary offering. Essentially, the firm is looking to raise more ...
Read Full Story »

Why Cara Therapeutics Shares Are Soaring

Cara Therapeutics Inc. (NASDAQ: CARA) shares made a solid gain on Wednesday after the firm announced that it has licensed rights to commercialize Korsuva (CR845/difelikefalin) injection for the treatment of ...
Read Full Story »

Esperion Therapeutics Shares Briefly Halted on Late-Stage Cholesterol Trial

Esperion Therapeutics Inc. (NASDAQ: ESPR) shares were halted in premarket trading on Wednesday after the firm announced late-stage trial results for its cholesterol drug. Specifically, the Phase 3 study evaluated bempedoic ...
Read Full Story »

Amgen Wins Another FDA Approval

Amgen Inc. (NASDAQ: AMGN) shares made a slight gain on Tuesday after it was announced that the U.S. Food and Drug Administration (FDA) approved its treatment of glucocorticoid-induced osteoporosis in ...
Read Full Story »

Dova Pharmaceuticals Slumps Despite FDA Approval

Dova Pharmaceuticals Inc. (NASDAQ: DOVA) shares dropped on Monday following a critical update from the U.S. Food and Drug Administration (FDA) on one of its subsidiaries. Essentially, the agency granted ...
Read Full Story »

Should Nabriva Be Seeing a Better Response for This Positive Trial?

Nabriva Therapeutics PLC (NASDAQ: NBRV) watched its shares take a step back on Monday's despite seeing positive results in its late-stage pneumonia trial. The stock was actually up about 17% ...
Read Full Story »

9 Companies Bracing for Big ASCO Reactions

This year marks the 54th annual meeting of the American Society of Clinical Oncology (ASCO). Biotech and pharmaceutical companies will descend on Chicago for a five-day all-out conference (June 1 ...
Read Full Story »

FDA Lists Brand-Name Drugmakers That Obstruct Generic Development

All three drugmakers included in the Dow Jones industrial index were on a list of drug companies published Thursday by the U.S. Food and Drug Administration (FDA) alleged to have withheld ...
Read Full Story »

Amgen’s Novel Migraine Treatment Gets Key Approval

Amgen Inc. (NASDAQ: AMGN) shares saw a nice bump after the U.S. Food and Drug Administration (FDA) on Thursday approved Aimovig (erenumab), Amgen's preventive treatment of migraine in adults. It ...
Read Full Story »

Why Jounce Shares Are Crumbling Ahead of ASCO

Jounce Therapeutics Inc. (NASDAQ: JNCE) watched its shares crumble on Thursday after the firm released data from its midstage cancer trial. This data comes at a pivotal point, not just ...
Read Full Story »

Why Evolus Shares Are Getting Slammed

Evolus Inc. (NASDAQ: EOLS) watched its shares come crashing down on Wednesday after the company announced that the U.S. Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) ...
Read Full Story »

Are Abaxis Shareholders Getting Enough in the Buyout?

Abaxis Inc. (NASDAQ: ABAX) shares hit an all-time high early on Wednesday after it was announced that Zoetis Inc. (NYSE: ZTS) would be acquiring the firm. The acquisition is expected ...
Read Full Story »

Are Xenon Pharmaceuticals Shares Making a Run?

Xenon Pharmaceuticals Inc. (NASDAQ: XENE) shares saw a handy gain on Tuesday after the firm announced positive data from a couple of its trials. Specifically, Xenon presented data from its ...
Read Full Story »

UBS Makes Big Health Care Swap in Top Performing Q-GARP Portfolio

Over the years, we have continued to cover the UBS Quality Growth at a Reasonable Price (Q-GARP) portfolio, and with good reason. The portfolio managers have always focused on high-quality ...
Read Full Story »

Big Biotechs Scare Off Short Sellers

The short interest data are out for the most recent settlement date, April 30. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, ...
Read Full Story »